ClinVar Miner

Submissions for variant NM_000454.5(SOD1):c.229G>T (p.Asp77Tyr)

dbSNP: rs1601157750
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics Inc RCV000993040 SCV001145741 likely pathogenic not provided 2019-01-14 criteria provided, single submitter clinical testing Not found in the total gnomAD dataset, and the data is high quality (0/250484 chr). Found in at least one symptomatic patient. Predicted to have a damaging effect on the protein. Damaging to protein function(s) relevant to disease mechanism.
Invitae RCV001858765 SCV002238431 pathogenic Amyotrophic lateral sclerosis type 1 2021-12-02 criteria provided, single submitter clinical testing Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SOD1 protein function. ClinVar contains an entry for this variant (Variation ID: 805494). This variant is also known as p.D76Y. This missense change has been observed in individuals with amyotrophic lateral sclerosis (PMID: 9365366, 18428003, 23286750, 25382069, 28430856). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 77 of the SOD1 protein (p.Asp77Tyr). Experimental studies have shown that this missense change affects SOD1 function (PMID: 19635794, 20189984, 23280792). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Asp77 amino acid residue in SOD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12215228; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.